Translocations are much rarer in CLL and here BCL2 overexpression is commonly driven by loss of inhibitory miRNAs associated with recurrent deletion of part of chromosome 13 [9]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.